Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli

Schumacher, A; Steinke, P; Bohnert, JA; Akova, M; Jonas, D; Kern, WV

doi:10.1093/jac/dki446

Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli

Copy For Citation

Schumacher A., Steinke P., Bohnert J., Akova M., Jonas D., Kern W.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol.57, no.2, pp.344-348, 2006 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 57 Issue: 2
Publication Date: 2006
Doi Number: 10.1093/jac/dki446
Title of Journal : JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Page Numbers: pp.344-348

Abstract

Objectives: 1-(1-Naphthylmethyl)-piperazine (NMP) has been shown to reverse multidrug resistance (MDR) in Escherichia coli overexpressing RND type efflux pumps, but there is no data on its activity in Enterobacteriaceae other than E. coli.